Haoxi Health Technology Stock Price, News & Analysis
Company Description
Haoxi Health Technology Limited (NASDAQ: HAO) is an online marketing solution provider headquartered in Beijing, China. Classified in the Communication Services sector under the advertising agencies industry, the company focuses on helping advertiser clients in the healthcare and medical aesthetics sectors reach and convert consumers through digital channels in the Chinese market.
According to the company’s disclosures, Haoxi Health Technology Limited specializes in serving healthcare industry advertiser clients. Its growth is described as being driven by the rise of news feed ads and the rapid development of the healthcare sector in China. The company positions itself as a provider of one-stop online marketing solutions, with a particular emphasis on online short video marketing.
Core business and services
Haoxi Health Technology Limited states that it offers services that cover the planning, producing, placing, and optimizing of online advertisements. These services are designed to help advertisers acquire, convert, and retain end consumers on various online media platforms. The company indicates that it generates revenue from one-stop online marketing solutions delivered through its operating entity, Beijing Haoxi Digital Technology Co. Ltd. in the People’s Republic of China.
The company’s operations center on digital advertising via mainstream video and social media channels in the Chinese market. It places advertisements on popular platforms in China such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Haoxi highlights its focus on reducing costs, increasing efficiency, and providing relatively easy-to-use online marketing solutions to advertisers.
Healthcare and medical aesthetics focus
Public statements from Haoxi Health Technology Limited emphasize that its advertiser client base is mainly in the healthcare industry. The company has also highlighted a specific focus on the growing “light medical aesthetics” segment, including laser and injection-based treatments. It notes that demand for personalized and high-quality services in healthcare and medical aesthetics, together with evolving consumer behavior, underpins its business development roadmap.
Through its wholly owned subsidiary Beijing Haoxi Digital Technology Co., Ltd., the company has launched a customized livestreaming agency strategy. This strategy is described as a full-cycle, closed-loop offering that spans pre-campaign planning, livestream initiation, and post-campaign analysis. It is tailored to healthcare and medical aesthetics clients and is intended to integrate consumer behavior with platform-specific operational strategies.
Digital advertising capabilities and platforms
Haoxi Health Technology Limited reports that it focuses on online short video marketing and news feed ads. Its services include traffic acquisition from mainstream online media platforms, content production, data analysis, and advertising campaign optimization. These services are delivered to advertisers through its operating entity in China.
The company has disclosed that it collaborates mainly with ByteDance media platforms and that the increasing popularity of these platforms among its advertiser customers has contributed to growth in the quantity of services delivered. Haoxi also notes that more people using online services has supported increased demand for its advertising solutions.
Technology and data analysis
In its financial reporting, Haoxi Health Technology Limited describes research and development expenses related to Bidding Compass, which it identifies as its online ads bidding analysis software. The company attributes part of its performance to the ability of this proprietary data analysis software to optimize ad placements.
In addition, Haoxi has announced a strategic partnership with Gauss Intelligence (Beijing) Technology Co., Ltd., a subsidiary of Global Mofy AI Ltd. Through this collaboration, the company aims to combine the Gausspeed generative AI platform with its own marketing application scenarios. The partnership is described as focusing on enhancing big data analysis, automating creative content generation, and improving intelligent decision-making processes for digital marketing.
Capital markets and listing
Haoxi Health Technology Limited’s Class A ordinary shares trade on the Nasdaq Capital Market under the ticker symbol HAO. The company has reported on actions related to its listing status, including receiving a Nasdaq notification regarding minimum bid price deficiency and later announcing that it had regained compliance with Nasdaq Listing Rule 5550(a)(2) after its shares met the minimum bid price requirement for the specified period.
The company has also disclosed a 1-for-25 reverse share split of its ordinary shares, approved at an annual general meeting of shareholders. Following the reverse share split, its Class A ordinary shares began trading on an adjusted basis on the Nasdaq Capital Market under the existing ticker symbol HAO. Haoxi has further reported follow-on public offerings and a private placement of Class A ordinary shares, with proceeds intended for working capital, general corporate purposes, business expansion, technology investment, and potential acquisitions or investments in technologies, solutions, or businesses, as described in its filings and press releases.
Business model and revenue generation
In its financial statements, Haoxi Health Technology Limited explains that it generates revenue from one-stop online marketing solutions. These solutions include traffic acquisition from mainstream online media platforms, content production, data analysis, and advertising campaign optimization. The company notes that its average revenue per client reflects both the average per unit-of-service price (described as the average price per click-through charged to advertiser customers) and the quantity of services (the number of click-throughs for each advertiser).
The company’s cost of revenue primarily consists of the purchase of online traffic from third-party media platforms (after deducting rebates) and salaries and benefits for business operation staff. Haoxi reports that increases in cost of revenue have been in line with increases in revenue, and it attributes changes in gross profit and margin partly to market competition and the need to offer rebates to some customers.
Research and development
Haoxi Health Technology Limited identifies research and development expenses as mainly consisting of salaries and benefits for R&D staff working on Bidding Compass, its online ads bidding analysis software. The company has reported increases in R&D expenses associated with higher salaries for R&D staff.
Corporate governance and shareholder matters
As a foreign private issuer, Haoxi Health Technology Limited files reports with the U.S. Securities and Exchange Commission on forms such as Form 20-F and Form 6-K. The company has filed notices of general meetings of shareholders, including an annual general meeting where the reverse share split was approved and an extraordinary general meeting referenced in a Form 6-K. It has also filed documents related to securities purchase agreements and the closing of private placements.
Risk and regulatory disclosures
In its public communications, Haoxi Health Technology Limited refers investors to the risk factors section of its registration statements and other filings with the SEC. These documents, as the company notes, discuss factors that could cause actual results to differ from forward-looking statements. The company emphasizes that forward-looking statements are subject to risks and uncertainties and that investors should review its SEC filings for more detailed information.
Summary
Overall, Haoxi Health Technology Limited describes itself as a Beijing-headquartered online marketing solution provider in China with a focus on healthcare industry advertiser clients. Its business centers on one-stop digital advertising solutions, particularly online short video and news feed ads, delivered through major Chinese media platforms. The company combines advertising planning, content production, traffic acquisition, data analysis, and campaign optimization, and it has highlighted both proprietary software development and AI-related partnerships as part of its approach to digital marketing.
Stock Performance
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Haoxi Health Technology (HAO) currently stands at 52.9 thousand shares, down 24.7% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 10.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Haoxi Health Technology (HAO) currently stands at 1.9 days, up 91.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 4.6 days.
